Altered expression of COX-1, COX-2, and mPGES in rats with nephrogenic and central diabetes insipidus

American Journal of Physiology - Renal Physiology

Volumn 288, Issue 5 57-5, 2005, Pages

  Kotnik, Primož ^a,b   Nielsen, Jakob ^a   Kwon, Tae Hwan ^a,c   Kržišnik, Ciril ^b   Frøkiær, Jørgen ^a   Nielsen, Søren ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b UNIVERSITY CHILDREN S HOSPITAL   (Slovenia)

^c Kyungpook National University School of Medicine   (South Korea)

Author keywords

Cyclooxygenase 2; DDAVP; Inner medullary interstitial cell; Medullary osmolality; Membrane associated prostaglandin E2 synthase; Prostaglandin; Urine concentration

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; LITHIUM; PROSTAGLANDIN E2 DERIVATIVE; PROSTAGLANDIN SYNTHASE; VASOPRESSIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; CELL DENSITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DESICCATION; DIABETES INSIPIDUS; EXPERIMENTAL MODEL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KIDNEY CORTEX; KIDNEY MEDULLA; MALE; NEPHROGENIC DIABETES INSIPIDUS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; STATISTICAL SIGNIFICANCE;

EID: 17644423913     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00114.2004     Document Type: Article

References (49)

1. 1 on renal water excretion. J Clin Invest 52: 463-471, 1973.
2. Campean V, Theilig F, Paliege A, Breyer M, and Bachmann S. Key enzymes for renal prostaglandin synthesis: site-specific expression in rodent kidney (rat, mouse). Am J Physiol Renal Physiol 285: F19-F32, 2003.
3. Castrop H, Vitzthum H, Schumacher K, Schweda F, and Kurtz A. Low tonicity mediates a downregulation of cyclooxygenase-1 expression by furosemide in the rat renal papilla. J Am Soc Nephrol 13: 1136-1144, 2002.
4. Christensen S, Kusano E, Yusufy AN, Murayama N, and Dousa TP. Pathogenesis of nephrogenic diabetes insipidus due to chronic administration of lithium in rats. J Clin Invest 75: 1869-1879, 1985.
5. DeWitt DL and Smith WL. Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence. Proc Natl Acad Sci USA 85: 1412-1416, 1988.
6. 2. Am J Physiol Renal Physiol 275: F955-F961, 1998.
7. 2 via the isoprostane pathway: a mechanism for the generation of bioactive prostoglandins independent of cyclooxygenase. J Biol Chem 278: 28479-28489, 2003.
8. 2 synthase. Am J Physiol Renal Physiol 281: F1173-F1177, 2001.
9. Haas M, Moolenaar F, Meijer DK, de Jong PE, and de Zeeuw D. Renal targeting of a non-steroidal anti-inflammatory drug: effects on renal prostaglandin synthesis in the rat. Clin Sci (Colch) 95: 603-609, 1998.
10. Hao CM, Komhoff M, Guan Y, Redha R, and Breyer MD. Selective targeting of cyclooxygenase-2 reveals its role in renal medullary interstitial cell survival. Am J Physiol Renal Physiol 277: F352-F359, 1999.
11. Harris RC. Interactions between COX-2 and the renin-angiotensin system in the kidney. Acta Physiol Scand 111: 423-427, 2003.
12. Harris RC and Breyer MD. Physiological regulation of cyclooxygenase-2 in the kidney. Am J Physiol Renal Physiol 281: F1-F11, 2001.
13. Harris RC, McKanna JA, Akai Y, Jacobson HR, Dubois RN, and Breyer MD. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J Clin Invest 94: 2504-2510, 1994.
14. 2 inhibits AVP-induced water flow in cortical collecting ducts by protein kinase C activation. Am J Physiol Renal Fluid Electrolyte Physiol 259: F318-F325, 1990.
15. 2 inhibits sodium transport in rabbit cortical collecting duct by increasing intracellular calcium. J Clin Invest 87: 1992-1998, 1991.
16. 2 receptors modulate water and sodium transport in rabbit cortical collecting duct. Am J Physiol Renal Fluid Electrolyte Physiol 265: F643-F650, 1993.
17. Hober C, Vantyghem MC, Racadot A, Cappoen JP, and Lefebvre J. Normal hemodynamic and coagulation responses to 1-deamino-8-D-arginine vasopressin in a case of lithium-induced nephrogenic diabetes insipidus. Results of treatment by a prostaglandin synthesis inhibitor (indomethacin). Horm Res 37: 190-195, 1992.
18. Hochberg Z, Even L, and Danon A. Amelioration of polyuria in nephrogenic diabetes insipidus due to aquaporin-2 deficiency. Clin Endocrinol (Oxf) 49: 39-44, 1998.
19. 2 synthesis in the inner medullary collecting duct of the rat: implications for vasopressin-dependent cyclic AMP formation. J Cell Physiol 129: 60-64, 1986.
20. 2 synthesis in the Brattleboro homozygous diabetes insipidus rat. Prostaglandins Leukot Med 22: 101-110, 1986.
21. Jakobsson PJ, Thoren S, Morgenstern R, and Samuelsson B. Identification of human prostaglandin E synthase: a microsomal glutathione-dependant, inducible enzyme, constituting a potential novel drug target. Proc Natl Acad Sci USA 96: 7720-7725, 1999.
22. Jensen BL and Kurtz A. Differential regulation of renal cyclooxygenase mRNA by dietary salt intake. Kidney Int 52: 1242-1249, 1997.
23. Kinter LB, Shier D, Flamenbaum W, and Beeuwkes R III. The renin angiotensin system in conscious Brattleboro strain rats. Ren Physiol 5: 278-285, 1982.
24. Knoers NV and Deen PM. Molecular and cellular defects in nephrogenic diabetes insipidus. Pediatr Nephrol 16: 1146-1152, 2001.
25. + transporters in rats with lithium-induced NDI. Am J Physiol Renal Physiol 279: F552-F564, 2000.
26. Libber S, Harrison H, and Spector D. Treatment of nephrogenic diabetes insipidus with prostaglandin synthesis inhibitors. J Pediatr 108: 305-311, 1986.
27. Maghnie M. Diabetes insipidus. Horm Res 59, Suppl 1: 42-54, 2003.
28. Marples D, Christensen S, Christensen EI, Ottosen PD, and Nielsen S. Lithium-induced downregulation of aquaporin-2 water channel expression in rat-kidney medulla. J Clin Invest 95: 1838-1845, 1995.
29. Morello JP and Bichet DG. Nephrogenic diabetes insipidus. Annu Rev Physiol 63: 607-630, 2001.
30. 2 responses to AVP and dDAVP in subjects with central and nephrogenic diabetes insipidus. Am J Physiol Renal Fluid Electrolyte Physiol 248: F354-F359, 1985.
31. 2 synthase that acts in concert with cyclooxygenase-2. J Biol Chem 275: 32783-32792, 2000.
32. 2 inhibits water permeability at a post-cAMP site in rat terminal inner medullary collecting duct. Am J Physiol Renal Fluid Electrolyte Physiol 262: F229-F235, 1992.
33. Nielsen J, Kwon TH, Praetorius J, Kim YH, Frøkiær J, Knepper MA, and Nielsen S. Segment-specific ENaC downregulation in kidney of rats with lithium-induced NDI. Am J Physiol Renal Physiol 285: F1198-F1209, 2003.
34. Nejsum NL, Zelenina M, Aperia A, Frøkiær J, and Nielsen S. Bidirectional regulation of AQP2 trafficking and recycling: involvement of AQP2-S256 phosphorylation. Am J Physiol Renal Physiol. doi:10.1152/ajprenal. 00291.2004. In press.
35. 2α in rabbits. Acta Physiol Scand 105: 367-373, 1979.
36. Parente L and Perretti M. Advances in the pathophysiology of constitutive and inducible cyclooxygenases: two enzymes in the spotlight. Biochem Pharmacol 65: 153-159, 2003.
37. Pattaragarn A and Alon US. Treatment of congenital nephrogenic diabetes insipidus by hydrochlorothiazide and cyclooxygenase-2 inhibitor. Pediatr Nephrol 18: 1073-1076, 2003.
38. Sakairi Y, Jacobson HR, Noland TD, and Breyer MD. Luminal prostaglandin E receptors regulate salt and water transport in rabbit cortical collecting duct. Am J Physiol Renal Fluid Electrolyte Physiol 269: F257-F265, 1995.
39. Smith WL, Garavito RM, and DeWitt DL. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 271: 33157-33160, 1996.
40. Sonnenburg WK and Smith WL. Regulation of cyclic AMP metabolism in rabbit cortical collecting tubule cells by prostaglandins. J Biol Chem 263: 6155-6160, 1988.
41. 2, cAMP, and vasopressin in lithium-induced polyuria. Am J Physiol Regul Integr Comp Physiol 254: R863-R869, 1988.
42. Takahashi N, Chernavvsky DR, Gomez RA, Igarashi P, Gitelman HJ, and Smithies O. Uncompensated polyuria in a mouse model of Bartter's syndrome. Proc Natl Acad Sci USA 97: 5434-5439, 2000.
43. 2 analogue sulprostone antagonizes vasopressin-induced antidiuresis through activation of Rho. J Cell Sci 116: 3285-3294, 2003.
44. Terris J, Ecelbarger CA, Nielsen S, and Knepper MA. Long-term regulation of four renal aquaporins in rats. Am J Physiol Renal Fluid Electrolyte Physiol 271: F414-F422, 1996.
45. 2 in nephrogenic diabetes insipidus: effects of inhibition of prostaglandin synthesis by indomethacin. J Pediatr 97: 476-478, 1980.
46. Vitzthum H, Abt I, Einhellig S, and Kurtz A. Gene expression of prostanoid forming enzymes along the rat nephron. Kidney Int 62: 1570-1581, 2002.
47. Wang D, McGiff JC, and Ferreri NR. Regulation of cyclooxygenase isoforms in the renal thick ascending limb: effects of extracellular calcium. J Physiol Pharmacol 51: 587-595, 2000.
48. Yang T, Schnermann JB, and Briggs JP. Regulation of cyclooxygenase-2 expression in renal medulla by tonicity in vivo and in vitro. Am J Physiol Renal Physiol 277: F1-F9, 1999.
49. 2 interaction with AVP: effects on AQP2 phosphorylation and distribution. Am J Physiol Renal Physiol 278: F388-F394, 2000.